The Thailand Hub of Talents in Cancer Immunotherapy (TTCI) is proud to have co-organized and led the Cell Therapy Program on the first day of the IPOPI-SEAPID-Chulalongkorn-Erasmus MC Meeting, held on 8–9 April 2025 at King Chulalongkorn Memorial Hospital, Bangkok.

TTCI spearheaded the morning session on April 8th, focusing on CAR T Cell Therapy: Principles and Clinical Use. The program featured a comprehensive series of lectures, starting from the fundamentals of CAR-T cells to GMP production processes, clinical applications in pediatric cancers, target discovery in solid tumors, and novel indications such as systemic lupus erythematosus (SLE). Distinguished speakers included Dr. Thanyavi Chinsuwan, Assoc. Prof. Supannikar Tawinwung, Dr. Koramit Suppipat, Zijun (Verna) Zhou, Prof. Nattiya Hirankarn, and Dr. Wonngarm Kittanamongkolchai, with active participation from TTCI faculty and collaborators.

This initiative highlights TTCI’s commitment to advancing knowledge, fostering collaboration, and promoting clinical translation of cell therapies both in Thailand and across the region.